BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31928060)

  • 1. [Epidemiology of early infections after autologous hematopoietic stem cell transplantation.
    Lakatos B; Szabó H; Csordás K; Tatai G; Nikolova R; Csomor J; Reményi P; Masszi T; Vályi-Nagy I; Sinkó J
    Orv Hetil; 2020 Jan; 161(3):103-109. PubMed ID: 31928060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of autologous hemopoietic stem cell transplantation in T-cell lymphoma. Hungarian data].
    Szomor Á; Csalódi R; Kosztolányi S; Nagy Á; Pammer J; Tóth O; Losonczy H; Alizadeh H; Miltényi Z; Reményi P; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1615-1619. PubMed ID: 29025289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
    Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
    Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.
    Srinivasan A; McLaughlin L; Wang C; Srivastava DK; Shook DR; Leung W; Hayden RT
    Transpl Infect Dis; 2014 Feb; 16(1):90-7. PubMed ID: 24256514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
    Palau J; Picón I; Angel Climent M; Martí R; Aznar E; Carmen Sanjuán M; Máiquez J
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):422-7. PubMed ID: 11709119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious Complications and Multidrug-Resistant Bacteria in Patients With Hematopoietic Stem Cell Transplantation in the First 12 Months After Transplant.
    César-Arce A; Volkow-Fernández P; Valero-Saldaña LM; Acosta-Maldonado B; Vilar-Compte D; Cornejo-Juárez P
    Transplant Proc; 2017; 49(6):1444-1448. PubMed ID: 28736021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
    Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
    Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.
    Mullen CA; Nair J; Sandesh S; Chan KW
    Bone Marrow Transplant; 2000 Jan; 25(1):59-65. PubMed ID: 10654016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group.
    Waszczuk-Gajda A; Drozd-Sokołowska J; Basak GW; Piekarska A; Mensah-Glanowska P; Sadowska-Klasa A; Wierzbowska A; Rzepecki P; Tomaszewska A; Mańko J; Hus M; Adamska M; Romejko-Jarosińska J; Dybko J; Biernat M; Kyrcz-Krzemień S; Sędzimirska M; Winciorek N; Jędrzejczak WW; Styczyński J; Giebel S; Gil L
    Transplant Proc; 2020 Sep; 52(7):2178-2185. PubMed ID: 32217016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.
    Ha VH; Ghosh S; Leyshon C; Ryan N; Chambers CR; Stewart DA
    J Oncol Pharm Pract; 2018 Jul; 24(5):323-331. PubMed ID: 28358279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.
    Kroschinsky F; Wichmann G; Bornhauser M; Ordemann R; Schuler U; Ehninger G; Hanel M
    Transpl Infect Dis; 2002 Sep; 4(3):132-6. PubMed ID: 12421457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
    Larsson K; Björkstrand B; Ljungman P
    Support Care Cancer; 1998 Jul; 6(4):378-83. PubMed ID: 9695206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
    Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
    Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.